Company page
Bridgebio Oncology Therapeutics, Inc.
Bridgebio Oncology Therapeutics, Inc. is a public company traded under the ticker BBOT in the American market. The company has a market capitalization of approximately $605.6 million. Bridgebio focuses on developing innovative therapies for various types of cancer.
- Ticker
- BBOT:NASDAQ
- Asset type
- Stock
- Market cap
- $605.6M
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD